mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.3 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.3 |
0.3 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |